Disease activity in pregnancy and postpartum in women with MS who suspended rituximab and natalizumab

OBJECTIVE: To evaluate risks of disease reactivity during pregnancy and postpartum following rituximab (RTX) and natalizumab (NTZ) suspension in women with MS. METHODS: An observational cohort study of all women with MS disease onset before childbirth between 2006 and 2017. Women were identified thr...

Descripción completa

Detalles Bibliográficos
Autores principales: Razaz, Neda, Piehl, Fredrik, Frisell, Thomas, Langer-Gould, Annette M., McKay, Kyla A., Fink, Katharina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641107/
https://www.ncbi.nlm.nih.gov/pubmed/33087582
http://dx.doi.org/10.1212/NXI.0000000000000903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641107/
https://www.ncbi.nlm.nih.gov/pubmed/33087582
http://dx.doi.org/10.1212/NXI.0000000000000903

Ejemplares similares